Insmed IncorporatedInsmed IncorporatedInsmed Incorporated

Insmed Incorporated

No trades
See on Supercharts
Market capitalization
‪4.24 B‬USD
−5.35USD
‪−749.57 M‬USD
‪305.21 M‬USD
‪144.65 M‬
Beta (1Y)
0.55

About Insmed Incorporated

CEO
William H. Lewis
Headquarters
Bridgewater
Website
Employees (FY)
912
Founded
1988
ISIN
US4576693075
FIGI
BBG000BWM5P3
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of INSM is 27.67 USD — it has decreased by 3.12% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Insmed Incorporated stocks are traded under the ticker INSM.
Insmed Incorporated is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Insmed Incorporated has a max estimate of 55.00 USD and a min estimate of 35.00 USD.
INSM earnings for the last quarter are −1.11 USD whereas the estimation was −1.14 USD which accounts for 2.72% surprise. Estimated earnings for the next quarter are −1.15 USD. See more details about Insmed Incorporated earnings.
Insmed Incorporated revenue for the last quarter amounts to ‪79.07 M‬ USD despite the estimated figure of ‪79.14 M‬ USD. In the next quarter revenue is expected to reach ‪81.88 M‬ USD.
Yes, you can track Insmed Incorporated financials in yearly and quarterly reports right on TradingView.
Like other stocks, INSM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Insmed Incorporated stock right from TradingView charts — choose your broker and connect to your account.
INSM reached its all-time high on Aug 30, 2000 with the price of 199.38 USD, and its all-time low was 2.64 USD and was reached on Nov 25, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 12, 2024, the company has 912.00 employees. See our rating of the largest employees — is Insmed Incorporated on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Insmed Incorporated EBITDA is ‪−661.93 M‬ USD, and current EBITDA margin is −219.64%. See more stats in Insmed Incorporated financial statements.